|
|
||||||||
The Journal of Immunology, Vol 158, Issue 3 1345-1352, Copyright © 1997 by American Association of Immunologists
ARTICLES |
WA Nockher and JE Scherberich
Laboratory of Immunology and Molecular Physiology, Department of Medicine IV, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
The effect of glucocorticoid (GC) treatment on expression and release of the monocyte cell surface LPS receptor Ag CD14 was studied in vivo and in vitro. In patients with acute inflammatory diseases receiving GC pulse therapy serum concentrations of soluble CD14 and CD14 expression by peripheral blood monocytes decreased significantly. The LPS-binding capacity correlated positively with the amount of cell surface CD14 by human blood monocytes. In vitro, a time- and dose-dependent effect of GC preparations on monocyte membrane and soluble CD14 by cultured peripheral blood monocytes was found. Incubation with 2 x 10(-8) M prednisolone down-regulated cell surface CD14 after 72 h, and 2 x 10(- 7) M suppressed CD14 expression even after 24 h. Prednisolone also decreased release of the soluble CD14 Ag, where a 10-fold higher GC concentration was required for a significant suppression compared with membrane CD14 during culture. Expression of other monocyte membrane Ags were either unchanged (CD33, CD35), diminished (CD13, CD89), or increased (CD32) by GC, indicating no general down-modulation of cell surface Ag expression. Preincubation with glucocorticoids for 24 h significantly down-regulated CD14 expression during subsequent steroid- free culture for at least 7 days. In cultured monocytes, the LPS- induced increase of membrane and soluble CD14 was markedly but not completely inhibited by prednisolone. Therefore, GC treatment suppresses the up-regulation of the LPS receptor during endotoxin challenge, and likewise, the IL-1 secretion after LPS stimulus was significantly diminished. Taken together, the suppression of the monocytic cell surface and soluble endotoxin receptor CD14 by GC may contribute to the increased risk of infections in patients undergoing steroid therapy.
This article has been cited by other articles:
![]() |
T. Shimizu, S.-i. Yokota, S. Takahashi, Y. Kunishima, K. Takeyama, N. Masumori, A. Takahashi, M. Matsukawa, N. Itoh, T. Tsukamoto, et al. Membrane-Anchored CD14 Is Important for Induction of Interleukin-8 by Lipopolysaccharide and Peptidoglycan in Uroepithelial Cells Clin. Vaccine Immunol., September 1, 2004; 11(5): 969 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Hepburn, J. C. Mason, and K. A. Davies Expression of Fc{gamma} and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis Rheumatology, May 1, 2004; 43(5): 547 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Creery, J. B. Angel, S. Aucoin, W. Weiss, W. D. Cameron, F. Diaz-Mitoma, and A. Kumar Nef Protein of Human Immunodeficiency Virus and Lipopolysaccharide Induce Expression of CD14 on Human Monocytes through Differential Utilization of Interleukin-10 Clin. Vaccine Immunol., November 1, 2002; 9(6): 1212 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kanatani, T. Kasukabe, J. Okabe-Kado, Y. Yamamoto-Yamaguchi, N. Nagata, K. Motoyoshi, and Y. Honma Role of CD14 Expression in the Differentiation-Apoptosis Switch in Human Monocytic Leukemia Cells Treated with 1{{alpha}},25-Dihydroxyvitamin D3 or Dexamethasone in the Presence of Transforming Growth Factor {beta} Cell Growth Differ., October 1, 1999; 10(10): 705 - 712. [Abstract] [Full Text] |
||||
![]() |
S. Launay, M. Gianni, T. Kovacs, R. Bredoux, A. Bruel, P. Gelebart, F. Zassadowski, C. Chomienne, J. Enouf, and B. Papp Lineage-Specific Modulation of Calcium Pump Expression During Myeloid Differentiation Blood, June 15, 1999; 93(12): 4395 - 4405. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, J. M. Cousin, J. Hughes, J. Van Damme, J. R. Seckl, C. Haslett, I. Dransfield, J. Savill, and A. G. Rossi Glucocorticoids Promote Nonphlogistic Phagocytosis of Apoptotic Leukocytes J. Immunol., March 15, 1999; 162(6): 3639 - 3646. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |